Mykor

Mykor

Private
BristolEnergy & Sustainabilityhttps://www.mykor.co.uk/

Last Round

Series A

May 27, 2026

Total Funding Raised

$8.82M

Company Overview

Mykor is a biotechnology company that manufactures carbon-negative insulation products for the construction industry.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Green Building, Construction Tech, Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

mycelium insulationcarbon-negative building materialsbiofabricationmushroom insulationsustainable building materialsgreen building materialsstructural insulated panelsSIPswaste upcyclingfire-resistant materialsembodied carbon reductionbiomaterialsthermal insulationacoustic insulationconstruction techengineered mycelium

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mykor Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mykor Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 27, 2026
GrantApr 29, 2025
SeedJul 8, 2024
Pre SeedApr 17, 2023

Key People

Founding team and executive leadership

Olivia Page

Co-Founder & CEO

Founding Team

Ricardo Félix

Diretor De Tecnologia - CTO

Executive Team

Mykor Investors

Notable investors and investment history

InvestorRounds
COREangelsSeed
Moonstone VCSeed
British Business BankSeries A
EPSRCGrant
Horizon EuropeGrant
Sustainable VenturesPre Seed
Innovate UKSeries A, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    $5.38M raised, led by Clean Growth Fund.

  • May 4, 2025

    Monthly visitors grew 34% MoM, reaching 1.1K.

Mykor Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mykor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mykor's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol
Employee Range23
Year Founded2021
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.